Lepu Medical Technology (Beijing) Co Ltd SZSE:300003:
SAYS UNIT SIGNS LICENSING AGREEMENT WITH DENMARK'S SIDERA BIO APS, TO RECEIVE 9.99% STAKE IN SIDERA AND UP TO $1 BILLION MILESTONE PAYMENTS
Lepu Medical Technology (Beijing)'s Unit Signs Licensing Agreement With Denmark's Sidera Bio Aps
Lepu Medical Technology (Beijing) Co., Ltd. on 6ix
Earlier from Lepu Medical Technology (Beijing)
- Lepu Medical Technology Co: Q3 net profit surged 176.18% year-over-year, driven by strong revenue and cash flow growth
- Lepu Medical Technology (Beijing) Q3 Net Profit Up 176.2% Y/Y
- Lepu Medical Technology Co: Revenue and net profit were stable, with strong cash flow and continued innovation leadership
- Lepu Medical Technology Co: Revenue and profit declined sharply, but innovation and global expansion drive future growth
- Lepu Medical Technology Co: Q3 saw steep profit and revenue declines, offset by growth in core medical device segments
Later from Lepu Medical Technology (Beijing)
- Lepu Medical Technology (Beijing) Sees 2025 Net Profit Up 224.0-386.0%
- Lepu Medical Technology (Beijing) Q1 Net Profit Down 34.8% Y/Y
- Lepu Medical Technology Co: 2025 saw record profit growth and strong innovation momentum amid industry transformation
Follow Lepu Medical Technology (Beijing) into a list and get an email when it puts out news.
Follow Lepu Medical Technology (Beijing)